Health Law Update

Home | Health Law Update

<img class="alignright wp-image-5806" src="https://ohioclockblog.bakerhostetlerblogs.com/wp-content/uploads/sites/27/2019/02/medical_pharmacy_Rx_prescription-drugs_64364509_LARGE.jpg" alt="White, blank doctor's prescription pad with an orange prescription medication bottle lying on top of it with pills spilling out of the bottle. The bottle has a blank label on it. Tan colored pills lay on top of prescription. A large &quot;RX&quot; is at the top left corner of the page. Pharmacy, healthcare, drugs, medicine concepts. Desk, table, countertop." width="375" height="250" />Senate Democrats recently introduced the Stop Price Gouging Act (S. 378), which seeks to place an excise tax on pharmaceutical companies in proportion to price spikes on prescription drugs.

The bill generally requires a company to justify to the Department of Health and Human Services (DHHS) any spike in prescription drug prices, but it is short on details regarding the criteria the inspector general of DHHS would have to abide by when analyzing the spike.

<a href="https://www.ohioclock.com/2019/02/senate-democrats-recently-introduced-the-stop-price-gouging-act/">Read more</a>.